KRT88P and hepatocellular carcinoma: The presence of anti-HBc antibodies in HBsAg-negative chronic hepatitis B patients can increase the risk of cirrhosis or hepatocellular carcinoma (HCC) as HBV-DNA can still be detected by PCR assay in serum and liver [2].